Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases

Journal of Pharmaceutical and Biomedical Analysis

Volumn 112, Issue , 2015, Pages 169-175

  Naldi, Marina ^a,b   Baldassarre, Maurizio ^a,b   Nati, Marina ^b   Laggetta, Maristella ^a,b   Giannone, Ferdinando Antonino ^a,b   Domenicali, Marco ^a,b   Bernardi, Mauro ^a,b   Caraceni, Paolo ^a,b   Bertucci, Carlo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Albumin dimers; Biomarkers; Human serum albumin isoforms; Mass spectrometry; Post translational modifications

Indexed keywords

DIMER; HUMAN SERUM ALBUMIN; HUMAN SERUM ALBUMIN DIMER; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; ISOPROTEIN; SERUM ALBUMIN;

ADULT; AMINO TERMINAL SEQUENCE; ANALYZER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIMERIZATION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; BIOSYNTHESIS; BLOOD; CHEMISTRY; CHRONIC DISEASE; LIVER CIRRHOSIS; MASS SPECTROMETRY; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; PROTEIN MULTIMERIZATION;

BIOMARKERS; CHRONIC DISEASE; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEIN ISOFORMS; PROTEIN MULTIMERIZATION; SERUM ALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84930178295     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.12.001     Document Type: Article

References (18)

1. Fanali G., di Masi A., Trezza V., Marino M., Fasano M., Ascenzi P. Human serum albumin: from bench to bedside. Mol. Aspects Med. 2012, 33:209-290.
2. Evans T.W. Review article: albumin as a drug - biological effects of albumin unrelated to oncotic pressure. Aliment. Pharmacol. Ther. 2002, 16(Suppl. 5):6-11.
3. Bal W., Sokołowska M., Kurowska E., Faller P. Binding of transition metal ions to albumin: sites, affinities and rates. Biochim. Biophys. Acta 2013, 1830:5444-5455.
4. Taverna M., Marie A.-L., Mira J.-P., Guidet B. Specific antioxidant properties of human serum albumin. Anaesth. Intensive Care 2013, 3:1-7.
5. Caraceni P., Domenicali M., Tovoli A., Napoli L., Ricci C.S., Tufoni M. Clinical indications for the albumin use: still a controversial issue. Eur. J. Intern. Med. 2013, 24:721-728.
6. Quinlan G.J., Martin G.S., Evans T.W. Albumin: biochemical properties and therapeutic potential. Hepatology 2005, 41:1211-1219.
7. Kleinova M., Belgacem O., Pock K., Rizzi A., Buchacher A., Allmaier G. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19:2965-2973.
8. Grigoryan H., Li H., Iavarone A.T., Williams E.R., Rappaport S.M. Cys34 adducts of reactive oxygen species in human serum albumin. Chem. Res. Toxicol. 2012, 25:1633-1642.
9. Domenicali M., Baldassarre M., Giannone F.A., Naldi M., Mastroroberto M., Biselli M., Laggetta M., Patrono D., Bertucci C., Bernardi M., Caraceni P. Posttransciptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis. Hepathology 2014, 60:1851-1860.
10. Naldi M., Giannone F.A., Baldassarre M., Domenicali M., Caraceni P., Bernardi M., Bertucci C. A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field. Eur. J. Mass Spectrom. 2013, 19:491-496.
11. Bar-Or D., Bar-Or R., Rael L.T., Gardner D.K., Slone D.S., Craun M.L. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit. Care Med. 2005, 33:1638-1641.
12. Furusyo N., Hayashi J. Glycated albumin and diabetes mellitus. Biochim. Biophys. Acta 2013, 1830:5509-5514.
13. Bar-Or D., Curtis G., Rao N., Bampos N., Lau E. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur. J. Biochem. 2001, 268:42-47.
14. Carballal S., Radi R., Kirk M.C., Barnes S., Freeman B.A., Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 2003, 42:9906-9914.
15. Ogasawara Y., Namai T., Togawa T., Ishii K. Formation of albumin dimers induced by exposure to peroxides in human plasma: a possible biomarker for oxidative stress. Biochem. Biophys. Res. Commun. 2006, 340:353-358.
16. Roche M., Rondeau P., Singh N.R., Tarnus E., Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008, 582:1783-1787.
17. Bar-Or R., Rael L.T., Bar-Or.D. Dehydroalanine derived from cysteine is a common post-translational modification in human serum albumin. Rapid Commun. Mass Spectrom. 2008, 22:711-716.
18. Medina-Navarro R., Durán-Reyes G., Díaz-Flores M., Vilar-Rojas C. Protein antioxidant response to the stress and the relationship between molecular structure and antioxidant function. PLoS ONE 2010, 5:e8971.